跳至主要内容
临床试验/NCT01484054
NCT01484054已完成不适用

Dispensing Evaluation of Lens Comfort and Subjective Vision of an Etafilcon A With Print and PVP Lens for Dark Eyes

Johnson & Johnson Vision Care, Inc.6 个研究点 分布在 1 个国家目标入组 103 人开始时间: 2011年11月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
103
试验地点
6
主要终点
Subject Reported Overall Quality of Lens Vision Using the Contact Lens User Evaluation (CLUE) Questionnaire

研究概览

简要总结

To evaluate and compare the performance of a new contact lens to a marketed contact lens.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 34 Years(Adult)
性别
Female
接受健康志愿者
否

入选标准

  • •The subject must be a healthy adult at least 18 years of age and no more than 34 years of age.
  • •The subjects must be female, dark eye Caucasian, Non-Hispanic habitual soft contact lens wearer (both eyes).
  • •The subject rated the Concept Statement positively (i.e., a rating of 4 or 5). If not the subject is not eligible to participate.
  • •The subject must have no known ocular or systemic allergies that might interfere with contact lens wear.
  • •The subject must have no known systemic disease, or need for medication, which might interfere with contact lens wear.
  • •The subject's optimal vertexed spherical equivalent distance correction must be between-1.00 and -4.00D.
  • •Any cylinder power must be:<=0.75D.
  • •The subject must have visual acuity best correctable to 20/25 or better for each eye.
  • •The subject must have normal eyes (no ocular medications or ocular infection of any type).
  • •The subject must read and sign the Statement of Informed Consent.
  • •The subject must appear able and willing to adhere to the instructions set forth in this clinical protocol.

排除标准

  • •Ocular or systemic allergies or disease which might interfere with contact lens wear.
  • •Systemic disease, autoimmune disease, or use of medication which might interfere with contact lens wear.
  • •Clinically significant (grade 3 or worse) corneal edema, corneal neovascularization, corneal staining, or any other abnormalities of the cornea which would contraindicate contact lens wear.
  • •Clinically significant (grade 3 or 4) tarsal abnormalities or bulbar injection which might interfere with contact lens wear.
  • •Any ocular infection.
  • •Any corneal distortion resulting from previous hard or rigid gas permeable contact lens wear.
  • •Any color deficiencies (color blindness) - to the best of the subject's knowledge.
  • •Pregnancy or lactation.
  • •Diabetes.
  • •Infectious diseases (e.g. hepatitis, tuberculosis) or an immuno-suppressive disease (e.g. HIV).
  • •Habitual contact lens type is toric, multifocal, or is worn as extended wear.
  • •Subject presents with one dark iris color and one light iris color
  • •Subject has heterochromia iridis (a difference in color between parts of one iris)
  • •The subject is an employee or family member of the clinical study site.

研究组 & 干预措施

EAPVPDE/EADE

Other

etafilcon A with embedded print and PVP lens for dark eyes worn daily during the first period of 7-9 days, then etafilcon A control lens worn daily during the second period of 7-9 days, with 1-3 days of wash-out time between the 2 periods.

干预措施: etafilcon A with print and PVP for dark eyes (EAPVPDE) (Device)

EAPVPDE/EADE

Other

etafilcon A with embedded print and PVP lens for dark eyes worn daily during the first period of 7-9 days, then etafilcon A control lens worn daily during the second period of 7-9 days, with 1-3 days of wash-out time between the 2 periods.

干预措施: etafilcon A control lens (EADE) (Device)

EADE/EAPVPDE

Other

etafilcon A control lens worn daily during the first period of 7-9 days, then etafilcon A with embedded print and PVP for dark eyes lens worn daily during the second period of 7-9 days, with 1-3 days of wash-out time between the 2 periods.

干预措施: etafilcon A with print and PVP for dark eyes (EAPVPDE) (Device)

EADE/EAPVPDE

Other

etafilcon A control lens worn daily during the first period of 7-9 days, then etafilcon A with embedded print and PVP for dark eyes lens worn daily during the second period of 7-9 days, with 1-3 days of wash-out time between the 2 periods.

干预措施: etafilcon A control lens (EADE) (Device)

结局指标

主要结局

Subject Reported Overall Quality of Lens Vision Using the Contact Lens User Evaluation (CLUE) Questionnaire

时间窗: After 7 to 9 days of lens wear

The overall quality of lens vision was assessed using the CLUE questionnaire after 7-9 days of follow-up. The CLUE Questionnaire is a validated patient-reported outcomes questionnaire to assess patient-experience attributes of soft, disposable contact lenses in the US, ages 18-65. Scores follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response with a range from 0-120.

Subject Reported Overall Lens Handling Using the Contact Lens User Evaluation (CLUE) Questionnaire

时间窗: After 7 to 9 days of lens wear

The overall lens handling was assessed using the CLUE questionnaire after 7-9 days of follow-up. The CLUE Questionnaire is a validated patient-reported outcomes questionnaire to assess patient-experience attributes of soft, disposable contact lenses in the US, ages 18-65. Scores follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response with a range of 0-120.

Subject Reported Overall Lens Comfort Using the Contact Lens User Evaluation (CLUE) Questionnaire

时间窗: After 7 to 9 days of lens wear

The overall lens comfort was assessed using the CLUE questionnaire after 7-9 days of follow-up.The CLUE Questionnaire is a validated patient-reported outcomes questionnaire to assess patient-experience attributes of soft, disposable contact lenses in the US, ages 18-65. Scores follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response with a range of 0-120.

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (6)

Loading locations...

相似试验